CD8A and infection: As early as 2-days after vaccination but before infection (day 0 of ZIKV challenge), E294-302-epitope specific CD8+ T cells were readily detectable in MVA-ZIKV vaccinated mice (~0.022% of total CD8+ T cells; Fig. 6B) as compared to the MVA-only vaccinated control mice.